Osinbajo: A pastor’s political dilemma – By: Gimba Kakanda
The storm rippling across the political camp of Vice President Yemi Osinbajo has initiated a difficult conversation in which, as usual, there’s no room for...
Month : March 2022
IGA Fund: Deep Discount, 8.25% Distribution Yield (NYSE:IGA)
byakkaya/E+ via Getty Images Written by Nick Ackerman, co-produced by Stanford Chemist. This article was originally published to members of the CEF/ETF Income Laboratory on...
3 Supercharged Tech Stocks to Buy Without Any Hesitation
With concerns over inflation and higher interest rates, growth stocks have taken it on the chin over the past few months. So is it time...
Lapsus$ Okta attack: Supply chain breach fears grow
Okta says there is “no evidence” of malicious activity resulting from an alleged cybersecurity breach by hacking gang Lapsus$, despite claims from the group today...
How has the pandemic altered NHS procurement? | HSJ Interactive
The past two years have highlighted the importance of effective procurement to the NHS, changing perceptions of the function – and, in some instances, its practice Sponsored...
Yale celebrates 2021 Dealer of Excellence Award winners
GREENVILLE, N.C. (March 23, 2022) – Yale Materials Handling Corporation announces winners of the 2021 Dealer of Excellence award, the company’s top honor for members...
This is how guns are made in a factory from scratch
Check out how guns are made in a gun factory. If the video player is not working, you can click on this alternative video link.Guns are...
Russian fleet sanctions squeezing capacity
Sanctions imposed on Russian aircraft fleets are further squeezing air cargo capacity in an already constrained market. Pierre Van Der Stichele, vice president of global...
The ESG conundrum proves the value of sustainable business
Evidence overwhelmingly suggests that companies, which get their ESG proposition right can create more business value. By paying attention to ESG concerns, companies don’t compromise...
‘David and Goliath:’ Safe Chain continues to deny allegations in counterfeiting HIV drug scheme | Local
CAMBRIDGE — As litigation in federal court continues between Cambridge-based pharmaceutical distributor Safe Chain Solutions and pharmaceutical manufacturer Gilead Sciences, Safe Chain maintains its denial...